EUCTR2005-000496-17-SE进行中（未招募）不适用
Atorvastatin in moderat active Crohns disease
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- Region Skåne
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with a moderate active Crohns disease defiened as a C-reactive plasma level > 2 mg/ml in absence of an infection and; endoscopic apperence of active inflammation or a CDAI > 150.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patients below the age of 18; a CDAI > 450; inability to leave informed consent; ongoing lipid lowering treatment; previous side effects to statin treatment; prednisolone dosage above 15 mg/day; and clinical significant kidney disease or aspartate aminotranspherase, alanine aminotranspherase, or kreatinine kinas above two times the upper reference level.
研究者
相似试验
已完成
2 期
Rosuvastatin for Acute Systemic Crohn's disease: A mono-center randomized trias diseaseCrohn's diseaseJPRN-UMIN000002074Department of lower gastroenterology, Hyogo College of Medicine45
已完成
2 期
Atorvastatin in Moderate Active Crohns DiseaseCrohns DiseaseNCT00454545Skane University Hospital12
Unknown
不适用
Pravastatin Therapy in Patients With Active Crohn's Disease: A Pilot StudyCrohn's DiseaseNCT00599625University of Virginia40
已完成
2 期
Therapeutic efficacy of atorvastatin in chronic idiopathic utricariaIdiopathic urticaria.Idiopathic urticariaIRCT201110033862N8Research Council of Mashhad University of Medical Sciences66
已完成
不适用
Atorvastastin and HIV associated immune activatioPACTR201301000445375Damalie Nakanjako30